Bao‐Dong Qin
- Oncology top 5%
- Physiology top 5%
- Rheumatology top 1%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Topics
- Lung Cancer Treatments and Mutations (18 papers)Cancer Immunotherapy and Biomarkers (11 papers)Cancer Genomics and Diagnostics (8 papers)
- Cited by
- RheumatologyPeriodonticsOncology
- Journals
- Nature CommunicationsGenes & DevelopmentSHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Bao‐Dong Qin
67 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 932
- Physiology 678
- Rheumatology 637
- Surgery 592
- Pulmonary and Respiratory Medicine 541
Countries citing papers authored by Bao‐Dong Qin
This map shows the geographic impact of Bao‐Dong Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bao‐Dong Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bao‐Dong Qin more than expected).
Fields of papers citing papers by Bao‐Dong Qin
This network shows the impact of papers produced by Bao‐Dong Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bao‐Dong Qin. The network helps show where Bao‐Dong Qin may publish in the future.
Co-authorship network of co-authors of Bao‐Dong Qin
This figure shows the co-authorship network connecting the top 25 collaborators of Bao‐Dong Qin. A scholar is included among the top collaborators of Bao‐Dong Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bao‐Dong Qin. Bao‐Dong Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | New clinical trial design in precision medicine: discovery, development and directionbreakdown → | 74 |
| 4 | 9 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | 21 | |
| 10 | 18 | |
| 11 | 25 | |
| 12 | 23 | |
| 13 | 40 | |
| 14 | 13 | |
| 15 | 4 | |
| 16 | 25 | |
| 17 | 22 | |
| 18 | 8 | |
| 19 | 12 | |
| 20 | 13 |
About Bao‐Dong Qin
Bao‐Dong Qin is a scholar working on Oncology, Hepatology and Cancer Research, having authored 71 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Rheumatology (637 citations), Periodontics (172 citations) and Oncology (932 citations). Bao‐Dong Qin has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Zaixing Yang, Renqian Zhong, Yan Liang, Ning Ma, Zhide Hu, Fenglou Huang, Yuan‐Sheng Zang, Jiaqi Wang, Xiao‐Dong Jiao and Min Yang. Their work appears in journals such as Nature Communications, Genes & Development and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.